Non-fluorouracil/cisplatin versus fluorouracil/cisplatin regimens in chemoradiation for esophageal cancer: a systematic review and meta-analysis.

Chen M, Ran J, Ding F, Zhao M

Open source

DOI
10.21037/tcr-2026-2030
Published
2026 Oct 30
Container
Translational cancer research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-2030,
  title = {Non-fluorouracil/cisplatin versus fluorouracil/cisplatin regimens in chemoradiation for esophageal cancer: a systematic review and meta-analysis.},
  author = {Chen M and Ran J and Ding F and Zhao M},
  year = {2026},
  journal = {Translational cancer research},
  doi = {10.21037/tcr-2026-2030},
  url = {https://doi.org/10.21037/tcr-2026-2030}
}

RIS

TY  - JOUR
TI  - Non-fluorouracil/cisplatin versus fluorouracil/cisplatin regimens in chemoradiation for esophageal cancer: a systematic review and meta-analysis.
AU  - Chen M
AU  - Ran J
AU  - Ding F
AU  - Zhao M
PY  - 2026
JO  - Translational cancer research
DO  - 10.21037/tcr-2026-2030
UR  - https://doi.org/10.21037/tcr-2026-2030
ER  - 

APA

M, C., J, R., F, D., & M, Z. (2026). Non-fluorouracil/cisplatin versus fluorouracil/cisplatin regimens in chemoradiation for esophageal cancer: a systematic review and meta-analysis.. Translational cancer research. https://doi.org/10.21037/tcr-2026-2030

Source records